Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Medical Studies
eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Share:
Share:
abstract:
Case report

Hypereosinophilic syndromes (HES) – different possible faces – a challenge for doctors of various specialisations. Case-based review

Małgorzata A. Czarny-Działak
1
,
Ewa Pater
2, 3
,
Cezary Pałczyński
1
,
Iwona Stanisławska
4

  1. Faculty of Medicine and Health Sciences,, Jan Kochanowski University, Kielce, Poland
  2. Healthcare Team, Włoszczowa, Poland
  3. Rheumatology Department, The John Paul III District Hospital, Włoszczowa, Poland
  4. Social Academy of Sciences, Collegium Medicum, Lodz, Poland
Medical Studies/Studia Medyczne
Online publish date: 2025/04/15
View full text Get citation
 
PlumX metrics:
For practical purposes, acquired eosinophilia can be divided into secondary, clonal, and idiopathic eosinophilia. The causes of secondary eosinophilia may be parasitic infections, allergic diseases, vasculitis, drug reactions, and lymphomas. Hypereosinophilic syndrome (HES) is a subcategory of essential eosinophilia. The diagnosis of idiopathic eosinophilia means that secondary and clonal eosinophilia have been excluded. The aim of this study was to present cases of patients with HES, showing the possible differentiation of organ involvement, which translates into various possible courses of HES. After analysing data from the literature on the clinical course of HES in our patients, we concluded that hypereosinophilic HES syndromes constitute a challenge for physicians of various specialisations. The common denominator connecting all cases will always be an increased number of eosinophilia and a good clinical response to anti-IL-5 antibody treatment.
keywords:

hypereosinophilic syndrome, eosinophilia, monoclonal antibodies

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.

Please note that since April 10th 2025 there is an NEW obligatory charge (= 600 Euro/3000 PLN) for each manuscript submitted and accepted for publication in journal Medical Studies/Studia Medyczne.

Detailed information is available here "Article Processing Charge (APC)"